Machelle Sanders

Filings by Machelle Sanders span 4 companies, the busiest being Biocryst Pharmaceuticals Inc, Novan, Inc. and Fortrea Holdings Inc. The record holds 15 filings, for trades running from 3 March 2020 to 3 August 2026.

In open-market terms, that means 1 purchase on one side and 5 sales worth €270k on the other. The totals do not cover 1 filing with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 6 share grants and 2 option exercises. So far in 2026, the count stands at no purchases and 1 sale.

Most recently, on 5 August 2026, the filings show an open-market sale worth €151k in Fortrea Holdings Inc. The last insider purchase was made public on 5 March 2020, 2,424 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.